Abstract
High tibial osteotomy (HTO) procedure is generally contraindicated in rheumatoid arthritis (RA) patients because synovial inflammation may exacerbate joint damage post-surgery. The natural course of joint destruction in RA changed dramatically with new treatment strategies and the introduction of biologic disease-modifying anti-rheumatic drugs (bDMARDs). We report the cases of two RA patients who underwent HTO and whose disease activities were well controlled by bDMARDs. Despite their short follow-up periods, they showed acceptable objective and subjective clinical results. We believe that the combination of bDMARDs and HTO can be indicated for selected RA patients before total knee arthroplasty.
Original language | English |
---|---|
Pages (from-to) | 537-542 |
Number of pages | 6 |
Journal | Acta medica Okayama |
Volume | 73 |
Issue number | 6 |
Publication status | Published - 2019 |
Keywords
- Biologic DMARD
- High tibial osteotomy
- Knee surgery
- Rheumatoid arthritis
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)